Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Plotnik

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Chemical Biology|June 22, 2021
Fighting PRC1 via the RINGJoshua P Plotnik
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Genome-Wide Analysis of RAS/ERK Signaling TargetsJoshua P Plotnik, Peter C Hollenhorst
Nucleic Acids Research|January 26, 2017
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2Joshua P Plotnik, Peter C Hollenhorst
Nucleic Acids Research|October 9, 2014
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cellsJoshua P Plotnik, Justin A Budka, Mary W Ferris, et al.
NAR Cancer|February 8, 2021
Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic targetBenjamin M Greulich, Joshua P Plotnik, Travis J Jerde, et al.
Molecular and Cellular Biology|October 22, 2014
Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migrationNagarathinam Selvaraj, Justin A Budka, Mary W Ferris, et al.
Cell Reports|October 27, 2016
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate CancerVivekananda Kedage, Nagarathinam Selvaraj, Taylor R Nicholas, et al.
Cancer Letters|November 28, 2017
ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinaseSunil Tomar, Joshua P Plotnik, James Haley, et al.
Molecular Cancer Research : MCR|May 15, 2024
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung CancerJoshua P Plotnik, Zheng Zha, Weiguo Feng, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Chemical Biology|June 22, 2021
Fighting PRC1 via the RINGJoshua P Plotnik
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Genome-Wide Analysis of RAS/ERK Signaling TargetsJoshua P Plotnik, Peter C Hollenhorst
Nucleic Acids Research|January 26, 2017
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2Joshua P Plotnik, Peter C Hollenhorst
Nucleic Acids Research|October 9, 2014
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cellsJoshua P Plotnik, Justin A Budka, Mary W Ferris, et al.
NAR Cancer|February 8, 2021
Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic targetBenjamin M Greulich, Joshua P Plotnik, Travis J Jerde, et al.
Molecular and Cellular Biology|October 22, 2014
Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migrationNagarathinam Selvaraj, Justin A Budka, Mary W Ferris, et al.
Cell Reports|October 27, 2016
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate CancerVivekananda Kedage, Nagarathinam Selvaraj, Taylor R Nicholas, et al.
Cancer Letters|November 28, 2017
ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinaseSunil Tomar, Joshua P Plotnik, James Haley, et al.
Molecular Cancer Research : MCR|May 15, 2024
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung CancerJoshua P Plotnik, Zheng Zha, Weiguo Feng, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
Pageof 2